Phospho-specific Smad3 signaling: Impact on breast oncogenesis
Volume 11, Issue 13
Purchase or Subscribe
July 1, 2012
Pages 2443 - 2451http://dx.doi.org/10.4161/cc.20546
: EMT, Smad3, TGFβ, breast cancer, cell cycle
Authors: Elizabeth Tarasewicz and Jacqueline S. Jeruss View affiliations
Members of the TGFβ superfamily are known to exert a myriad of physiologic and pathologic growth controlling influences on mammary development and oncogenesis. In epithelial cells, TGFβ signaling inhibits cell growth through cytostatic and pro-apoptotic activities but can also induce cancer cell EMT and, thus, has a dichotomous role in breast cancer biology. Mechanisms governing this switch are the subject of active investigation. Smad3 is a critical intracellular mediator of TGFβ signaling regulated through phosphorylation by the TGFβ receptor complex at the C terminus. Smad3 is also a substrate for several other kinases that phosphorylate additional sites within the Smad protein. This discovery has expanded the understanding of the significance and complexity of TGFβ signaling through Smads. This review highlights recent advances revealing the critical role of phospho-specific Smad3 in malignancy and illustrates the potential prognostic and therapeutic impact of Smad3 phospho-isoforms in breast cancer.
Received: April 17, 2012; Accepted: April 28, 2012
Full Text - Ahead of Print Available - Log in!